Startup Nation Central (SNC), the Israeli non-profit organization that tracks the local innovation ecosystem, has launched a comprehensive, updated directory with over 70 Israeli high-tech companies that offer medical technology solutions in the fight against COVID-19, the disease caused by the novel coronavirus.
The companies in the new directory provide “a variety of solutions to reduce the burden on health systems and limit direct contact with potential patients in countries dealing with the crisis,” the organization said in a statement.
The updated list of companies can be found under the tag #coronavirus on the Start-Up Nation Finder website. The goal is to help locate, promote, and finance Israeli technological solutions, SNC said.
“Israeli innovation can help to cope with the corona crisis, which is placing a growing existential danger before the whole world. The Israeli brain has extensive experience of times of emergency and thinking outside the box, and we want to do our bit in this difficult hour,” said Professor Eugene Kandel, CEO of Startup Nation Central and former chairman of Israel’s National Economic Council.
The directory includes a description of the relevant companies, a description of the solution they offer, the product development phase, and information about the companies’ funding.
“Various technologies developed in Israel are relevant for many aspects in the global fight with the coronavirus – headed by rapid and smart diagnosis that will reduce the enormous burden on hospitals, help prioritize critical tasks and protect the health of medical staff,” Prof. Kandel added.
The directory is comprised of five categories including remote monitoring, diagnostics and decision support, protection and prevention, social and mental aspects, and treatment.
The largest concentration of companies is found in the remote monitoring category, including firms that enable remote diagnoses of patients and suspected patients while minimizing the exposure of medical teams and prioritizing the treatment of patients according to the severity of their illness.
The second-largest category is diagnostics and decision support for medical teams. The category includes companies that enable identifying patients according to samples of their voice, various symptoms and data entered into the system about symptomatic patients who are at a higher risk in the first place.
“Start-Up Nation Central is in contact with medical institutions, governments and organizations worldwide, and is ready to help as much as needed to make these technologies, which can save lives, accessible,” Professor Kandel said.